Global Athlete′s Foot Drugs Market, By Type (Interdigital, Mocassin, Vesicular), Treatment (Topical, Oral Antifungal Medication, Topical Oral Steroid, Oral Antibiotics), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.
Athlete′s foot Drugs Market Analysis and Size
The global athlete′s foot drugs market is expected to witness significant growth during the forecast period. According to National Center for Biotechnology Information (NCBI) records, an athlete's foot is very common with an occurence rate of an estimated 3 to 15% of the population. Oral segment witnessed to have a huge growth and is readjusted to a revised 2.9% CAGR for the next 7-year period. The athlete's foot drug is used to treat fungal infection of the feet, which causes the scaling and blistering of the soles, fissures at toes, and painful and burning sensations along itching rashes.
Data Bridge Market Research analyses a growth rate in the global athlete′s foot drugs market in the forecast period 2023-2030. The expected CAGR of global athlete′s foot drugs market is tend to be around 6% in the mentioned forecast period. The market was valued at USD 0.94 billion in 2022, and it would grow upto USD 1.5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Athlete′s foot Drugs Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Interdigital, Mocassin, Vesicular), Treatment (Topical, Oral Antifungal Medication, Topical Oral Steroid, Oral Antibiotics), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Bausch Health Companies Inc. (Canada), DermBiont, Inc (U.S.), Blueberry Therapeutics Ltd (U.K.), Novan, Inc. (U.S.), Janssen Global Services, LLC (U.S.), Bayer AG (Germany), GSK plc (U.K.), Walgreen Co (U.S.), Qilu Pharmaceutical Co., Ltd. (China), Taisho Pharmaceutical Holdings Co., Ltd. (Japan), Taro Pharmaceutical Industries Ltd (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Athlete's foot, also known as tinea pedis, is a type of viral infection of the fungus which affects the feet. This can spread to the toe nails and hands. It is more commonly seen in athletes, hence the name. The infection can cause scaling, itching, and blisters on the soles and sides of the feet. Athlete's foot drugs involves medications which are used to treat this condition. It includes antifungal medications such as terbinafine (Lamisil) and itraconazole (Sporanox), as well as topical corticosteroids such as betamethasone (Dermovate). These drugs help to clear up the infection and relieve symptoms.
Global Athlete′s foot Drugs Market Dynamics
Drivers
- Increasing Cases of Sports Injuries
The increasing occurrence and incidence of several sports injuries boost the growth of the market. According to the British Journal of Sports Medicine, about 1 million people are treated for sports-related injuries every year in the U.K. and this number is projected to increase by 50% over the next few years. Thus, it acts as a major driver in the market growth.
- Increase in the number of research and development activities
The market's growth is fuelled by the rise in the number of R&D activities. This will provide beneficial opportunities for the global athlete′s foot drugs market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.
Opportunities
- Growing Strategic Acquisitions
The key market players are contributing majorly to the growth of the market by the adoption of numerous strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to involve in the competition in the market. For instance, in April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals. The aim is to develop a new treatment for drug-resistant "superbug" for antifungal treatment. Thus, all of these factors are projected to contribute to partial growth in the forecast period.
- Increasing Demand for Retail Pharmacies
The rise in the number of drugs used for global athlete′s foot drugs market delivered through retail pharmacies and the establishment in the number of retail pharmacies in developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified healthcare professionals who are unable to perform these treatments could decrease the growth of the global athlete′s foot drugs market during a forecast period.
- Unavailability of Appropriate Treatments
To treat conditions which are rare, sometimes all treatments are not available, particularly in the under-developed countries. The severe patients needs to be treated with the advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.
This global athlete′s foot drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global athlete′s foot drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Athlete′s Foot Drugs Market Scope
The global athlete′s foot drugs market is segmented on the basis of type, treatment, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Interdigital
- Mocassin
- Vesicular
Treatment
- Topical
- Oral Antifungal Medication
- Topical Oral Steroid
- Oral Antibiotics
Route of Administration
- Oral
- Topical
- Others
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Athlete′s Foot Drugs Market Regional Analysis/Insights
The global athlete′s foot drugs market is analysed and market size insights and trends are provided by type, treatment, route of administation, end-user, distribution channel as referenced above.
The major countries covered in the global athlete′s foot drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the market due to easy access to healthcare facilities and increased investments in healthcare by leading market players.
Asia-Pacific is considered to have the most lucrative period due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Athlete′s Foot Drugs Market Share Analysis
The global athlete′s foot drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global athlete′s foot drugs market.
Key players operating in the global athlete′s foot drugs market include:
- Bausch Health Companies Inc. (Canada)
- DermBiont, Inc (U.S.)
- Blueberry Therapeutics Ltd (U.K.)
- Novan, Inc. (U.S.)
- Janssen Global Services, LLC (U.S.)
- Bayer AG (Germany)
- GSK plc (U.K.)
- Walgreen Co (U.S.)
- Qilu Pharmaceutical Co., Ltd. (China)
- Taisho Pharmaceutical Holdings Co., Ltd. (Japan)
- Taro Pharmaceutical Industries Ltd (U.S.)
Research Methodology: Global Athlete′s Foot Drugs Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
SKU-